Genky DrugStores Co., Ltd. (JP:9267) has released an update.
Genky DrugStores Co., Ltd. reports robust financial performance for the fiscal year ended June 20, 2024, with a 9.3% increase in net sales and over 30% growth in operating and ordinary income. The company’s net income attributable to owners of parent also rose significantly by 32.7%, reflecting a strong financial position with an equity ratio of 40.9%. Looking ahead, Genky forecasts continued revenue and net income growth for the next fiscal year, maintaining a positive outlook for investors.
For further insights into JP:9267 stock, check out TipRanks’ Stock Analysis page.